191 related articles for article (PubMed ID: 19053323)
1. Mapping DNA adducts of mitomycin C and decarbamoyl mitomycin C in cell lines using liquid chromatography/ electrospray tandem mass spectrometry.
Paz MM; Ladwa S; Champeil E; Liu Y; Rockwell S; Boamah EK; Bargonetti J; Callahan J; Roach J; Tomasz M
Chem Res Toxicol; 2008 Dec; 21(12):2370-8. PubMed ID: 19053323
[TBL] [Abstract][Full Text] [Related]
2. Formation of a major DNA adduct of the mitomycin metabolite 2,7-diaminomitosene in EMT6 mouse mammary tumor cells treated with mitomycin C.
Palom Y; Belcourt MF; Kumar GS; Arai H; Kasai M; Sartorelli AC; Rockwell S; Tomasz M
Oncol Res; 1998; 10(10):509-21. PubMed ID: 10338154
[TBL] [Abstract][Full Text] [Related]
3. Structure of adduct X, the last unknown of the six major DNA adducts of mitomycin C formed in EMT6 mouse mammary tumor cells.
Palom Y; Belcourt MF; Musser SM; Sartorelli AC; Rockwell S; Tomasz M
Chem Res Toxicol; 2000 Jun; 13(6):479-88. PubMed ID: 10858321
[TBL] [Abstract][Full Text] [Related]
4. Relative toxicities of DNA cross-links and monoadducts: new insights from studies of decarbamoyl mitomycin C and mitomycin C.
Palom Y; Suresh Kumar G; Tang LQ; Paz MM; Musser SM; Rockwell S; Tomasz M
Chem Res Toxicol; 2002 Nov; 15(11):1398-406. PubMed ID: 12437330
[TBL] [Abstract][Full Text] [Related]
5. Bioreductive metabolism of mitomycin C in EMT6 mouse mammary tumor cells: cytotoxic and non-cytotoxic pathways, leading to different types of DNA adducts. The effect of dicumarol.
Palom Y; Belcourt MF; Tang LQ; Mehta SS; Sartorelli AC; Pritsos CA; Pritsos KL; Rockwell S; Tomasz M
Biochem Pharmacol; 2001 Jun; 61(12):1517-29. PubMed ID: 11377381
[TBL] [Abstract][Full Text] [Related]
6. Adducts of mitomycin C and DNA in EMT6 mouse mammary tumor cells: effects of hypoxia and dicumarol on adduct patterns.
Bizanek R; Chowdary D; Arai H; Kasai M; Hughes CS; Sartorelli AC; Rockwell S; Tomasz M
Cancer Res; 1993 Nov; 53(21):5127-34. PubMed ID: 7693331
[TBL] [Abstract][Full Text] [Related]
7. Selective activation of mitomycin A by thiols to form DNA cross-links and monoadducts: biochemical basis for the modulation of mitomycin cytotoxicity by the quinone redox potential.
Paz MM; Das A; Palom Y; He QY; Tomasz M
J Med Chem; 2001 Aug; 44(17):2834-42. PubMed ID: 11495594
[TBL] [Abstract][Full Text] [Related]
8. DNA adduct of the mitomycin C metabolite 2,7-diaminomitosene is a nontoxic and nonmutagenic DNA lesion in vitro and in vivo.
Utzat CD; Clement CC; Ramos LA; Das A; Tomasz M; Basu AK
Chem Res Toxicol; 2005 Feb; 18(2):213-23. PubMed ID: 15720125
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic potential of monoalkylation products between mitomycins and DNA: studies of decarbamoyl mitomycin C in wild-type and repair-deficient cell lines.
Kim SY; Rockwell S
Oncol Res; 1995; 7(5):39-47. PubMed ID: 8534933
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic potential of monoalkylation products between mitomycins and DNA: studies of decarbamoyl mitomycin C in wild-type and repair-deficient cell lines.
Rockwell S; Kim SY
Oncol Res; 1995; 7(1):39-47. PubMed ID: 7549043
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of Mitomycin C and Decarbamoylmitomycin C N(2) deoxyguanosine-adducts.
Champeil E; Cheng SY; Huang BT; Conchero-Guisan M; Martinez T; Paz MM; Sapse AM
Bioorg Chem; 2016 Apr; 65():90-9. PubMed ID: 26894558
[TBL] [Abstract][Full Text] [Related]
12. Differential activation of p53 by the various adducts of mitomycin C.
Abbas T; Olivier M; Lopez J; Houser S; Xiao G; Kumar GS; Tomasz M; Bargonetti J
J Biol Chem; 2002 Oct; 277(43):40513-9. PubMed ID: 12183457
[TBL] [Abstract][Full Text] [Related]
13. Differential toxicity of DNA adducts of mitomycin C.
Bargonetti J; Champeil E; Tomasz M
J Nucleic Acids; 2010 Jul; 2010():. PubMed ID: 20798760
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of an oligodeoxyribonucleotide adduct of mitomycin C by the postoligomerization method via a triamino mitosene.
Champeil E; Paz MM; Ladwa S; Clement CC; Zatorski A; Tomasz M
J Am Chem Soc; 2008 Jul; 130(29):9556-65. PubMed ID: 18588303
[TBL] [Abstract][Full Text] [Related]
15. Mitomycin dimers: polyfunctional cross-linkers of DNA.
Paz MM; Kumar GS; Glover M; Waring MJ; Tomasz M
J Med Chem; 2004 Jun; 47(12):3308-19. PubMed ID: 15163210
[TBL] [Abstract][Full Text] [Related]
16. Isolation and Rationale for the Formation of Isomeric Decarbamoylmitomycin C- N
Zacarias O; Aguilar W; Paz MM; Tsukanov S; Zheng M; Cheng SY; Pradhan P; Champeil E
Chem Res Toxicol; 2018 Aug; 31(8):762-771. PubMed ID: 30035537
[TBL] [Abstract][Full Text] [Related]
17. Interdependent Sequence Selectivity and Diastereoselectivity in the Alkylation of DNA by Decarbamoylmitomycin C.
Aguilar W; Paz MM; Vargas A; Zheng M; Cheng SY; Champeil E
Chemistry; 2018 Sep; 24(50):13278-13289. PubMed ID: 29958326
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of Mitomycin C and decarbamoylmitomycin C N
Zheng M; Hwang S; Snyder T; Aquilina J; Proni G; Paz MM; Pradhan P; Cheng SY; Champeil E
Bioorg Chem; 2019 Nov; 92():103280. PubMed ID: 31539740
[TBL] [Abstract][Full Text] [Related]
19. Insight Into Factors Governing Formation, Synthesis and Stereochemical Configuration of DNA Adducts Formed by Mitomycins.
Paz MM; Champeil E
Chem Rec; 2023 Jan; 23(1):e202200193. PubMed ID: 36251922
[TBL] [Abstract][Full Text] [Related]
20. DNA adducts of decarbamoyl mitomycin C efficiently kill cells without wild-type p53 resulting from proteasome-mediated degradation of checkpoint protein 1.
Boamah EK; Brekman A; Tomasz M; Myeku N; Figueiredo-Pereira M; Hunter S; Meyer J; Bhosle RC; Bargonetti J
Chem Res Toxicol; 2010 Jul; 23(7):1151-62. PubMed ID: 20536192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
